Sigyn Therapeutics, Inc. Sigyn Therapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Sigyn Therapy™
  • Oncology
    • Overview
    • ImmunePrep™
    • ChemoPrep™
    • ChemoPure™
  • News
    • Press Releases
    • Presentations
    • Resources
  • Media
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Email Alerts
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact
  • CEO Notes

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
  • Email Alerts
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Feb 01, 2024 6:25pm EST

Sigyn Therapeutics Completes Reverse Stock Split

Jan 30, 2024 8:45am EST

Sigyn Therapeutics Announces Reverse Stock Split

Jan 04, 2024 8:00am EST

Sigyn Therapeutics Releases Letter to Shareholders

Dec 12, 2023 8:30am EST

Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial Officer

Nov 14, 2023 5:11pm EST

Sigyn Therapeutics Reports Third Quarter 2023 Financial Results

Oct 04, 2023 8:30am EDT

Sigyn Therapeutics™ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment Toxicity

Sep 06, 2023 8:00am EDT

Sigyn Therapeutics to Present at Today’s Emerging Growth Conference and Tomorrow at the National Investment Bankers Association Conference

Aug 14, 2023 4:30pm EDT

Sigyn Therapeutics Reports Second Quarter 2023 Financial Results

Aug 08, 2023 10:30am EDT

Sigyn Therapeutics to Present at Tomorrow’s Emerging Growth Conference

Jul 31, 2023 8:35am EDT

Sigyn Therapeutics to Present at the OTCQB Venture Virtual Investor Conference on August 3rd

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2025 Sigyn Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap